Related Experiment Video

Updated: Aug 14, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

New therapeutics targets in chronic viral cardiomyopathy

W Poller1, H Fechner, U Kühl

  • 1Department of Cardiology and Pneumology, Campus-Benjamin Franklin, Charité University Medicine Berlin, Germany. wolfgang.poller@charite.de

Ernst Schering Research Foundation Workshop
|December 7, 2005
PubMed

Insights

Dilated cardiomyopathy (DCM) may stem from chronic viral infections. Research explores new molecular targets for antiviral therapies in virus-positive DCM patients, focusing on chronic viral cardiomyopathy.

Area of Science:

  • Cardiology
  • Virology
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a common heart muscle disease.
  • Cardiotropic viruses are implicated as pathogenic factors in human DCM.
  • Virus-positive DCM may be classified as chronic viral cardiomyopathy.

Purpose of the Study:

  • To investigate potential molecular targets for antiviral strategies in chronic viral cardiomyopathy.
  • To explore novel therapeutic approaches for patients with virus-positive DCM.

Main Methods:

  • Review of current clinical research on cardiotropic viruses and DCM.
  • Discussion of potential molecular targets including cellular virus uptake, signaling pathways, and protein interactions.
  • Analysis of challenges and solutions for antiviral therapies in chronic viral infections.

Main Results:

  • Interferon-beta has shown efficacy in eliminating adenovirus or coxsackievirus.
  • Identified three key areas for molecular targeting: virus entry, signaling pathways, and viral protein interactions.
  • Highlighted the distinct challenges of treating chronic viral infections compared to acute ones.

Conclusions:

  • Virus-positive DCM warrants virological research and consideration for antiviral strategies.
  • Novel molecular targets offer potential for treating chronic viral cardiomyopathy.
  • Addressing chronic viral infections requires tailored therapeutic approaches distinct from acute viral treatments.

More Related Videos

Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...